The Reduced Release of GH by GHRH in 8 Subjects Aged 65–69 Years Is Augmented Considerably by Rivastigmine, a Drug for Alzheimer’s Disease

Rudolf P. Obermayr,Lothar Mayerhofer,Maarten Knechtelsdorfer,Karl Heinz Tragl,Georg Geyer

The Reduced Release of GH by GHRH in 8 Subjects Aged 65–69 Years Is Augmented Considerably by Rivastigmine, a Drug for Alzheimer’s Disease

2003

Rudolf P. Obermayr
Lothar Mayerhofer
Maarten Knechtelsdorfer
Karl Heinz Tragl
Georg Geyer

Background: The growth hormone (GH) secretion declines by 14% with each decade of adult life. Several attempts have been made to reverse the manifestations of the senile GH deficien

Keywords:

Hormone
Rivastigmine
Diabetes mellitus
Endocrinology
Area under the curve
Alzheimer's disease
Side effect
Acetylcholinesterase
Growth hormone–releasing hormone
Medicine
Internal medicine
Degenerative disease
Chemotherapy
Central nervous system disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations